Novo Nordisk’s GLP-1 agonist Victoza has become the first non-insulin drug to be approved in the US as a treatment for type 2 diabetes in children for almost two decades. The FDA says the okay to use ...
WLTP - EC (kWh/100km) - Extra High - TEH 21.8 WLTP - EC (kWh/100km) - Extra High - TEL 21.1 WLTP - EC (kWh/100km) - High 13.8 WLTP - EC (kWh/100km) - High - TEH 14.2 WLTP - EC (kWh/100km) - High - TEL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results